The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Open accessAbstract
Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain thresholds and damages tissues. Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained reduction in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function. This approach can therefore be effective in treating common conditions such as post-infarction heart failure, and trials targeting a broad spectrum of new indications are underway. So far, three IL-1-targeted agents have been approved: the IL-1 receptor antagonist anakinra, the soluble decoy receptor rilonacept and the neutralizing monoclonal anti-IL-1β antibody canakinumab. In addition, a monoclonal antibody directed against the IL-1 receptor and a neutralizing anti-IL-1α antibody are in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Ferrara, J. L., Levine, J. E., Reddy, P., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,464
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Self-citationInflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001) · Nature Genetics · doi:10.1038/ng756 · Cited by 1,682
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
Colotta, F., Re, F., Polentarutti, N., Sozzani, S., & Mantovani, A. (1992) · Blood · doi:10.1182/blood.v80.8.2012.2012 · Cited by 1,158
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
Self-citationHorror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
Self-citationGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Tedgård, U., Cowen, E. W., Pham, T.-H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 987
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
Pascual, V., Allantaz, F., Arce, E., Punaro, M., & Banchereau, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050473 · Cited by 922
Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., Gitton, X., Widmer, A., Patel, N., & Hawkins, P. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810787 · Cited by 869
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.-Y., Sack, M. N., Kastner, D. L., & Siegel, R. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102049 · Cited by 860
Self-citationRidker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
A pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727
Cancer-related inflammation: Common themes and therapeutic opportunities
Balkwill, F. R., & Mantovani, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.005 · Cited by 685
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Self-citationHoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Quartier, P., Allantaz, F., Cimaz, R., Pillet, P., Messiaen, C., Bardin, C., Bossuyt, X., Boutten, A., Bienvenu, J., Duquesne, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.134254 · Cited by 558
Chae, J. J., Wood, G., Masters, S. L., Richard, K., Park, G., Smith, B. J., & Kastner, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602081103 · Cited by 554
Hoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L., Anderson, J. P., Wanderer, A. A., & Firestein, G. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17401-1 · Cited by 552
Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G., & Libby, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1902 · Cited by 537
Self-citationChevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D., & Appleton, B. E. (2009) · Arthritis Care & Research · doi:10.1002/art.24096 · Cited by 533
Solovic, I., Sester, M., Gomez-Reino, J. J., Rieder, H. L., Ehlers, S., Milburn, H. J., Kampmann, B., Hellmich, B., Groves, R., Schreiber, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00028510 · Cited by 527
IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C. A., & Apte, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102048 · Cited by 522
Self-citationDewhirst, F. E., Stashenko, P. P., Mole, J. E., & Tsurumachi, T. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2562 · Cited by 507
Identification of a membrane-associated interleukin 1 in macrophages.
Kurt-Jones, E. A., Beller, D. I., Mizel, S. B., & Unanue, E. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1204 · Cited by 493
Fisher, C. J., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., & Catalano, M. A. (1994) · Critical Care Medicine · doi:10.1097/00003246-199401000-00008 · Cited by 490
Autoinflammatory Disease Reloaded: A Clinical Perspective
Kastner, D. L., Aksentijevich, I., & Goldbach-Mansky, R. (2010) · Cell · doi:10.1016/j.cell.2010.03.002 · Cited by 487
Role of IL-1α and IL-1β in Ischemic Brain Damage
Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., & Rothwell, N. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05528.2001 · Cited by 477
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Emsley, H. C. A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054882 · Cited by 445
Abbate, A., Kontos, M. C., Grizzard, J. D., Biondi-Zoccai, G. G. L., Van Tassell, B. W., Robati, R., Roach, L. M., Arena, R. A., Roberts, C. S., Varma, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.059 · Cited by 415
Self-citationAn Autoinflammatory Disease Due to Homozygous Deletion of the IL1RN Locus
Reddy, S., Jia, S., Geoffrey, R., Lorier, R., Suchi, M., Broeckel, U., Hessner, M. J., & Verbsky, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809568 · Cited by 411
Lequerré, T., Quartier, P., Rosellini, D., Alaoui, F., De Bandt, M., Mejjad, O., Kone-Paut, I., Michel, M., Dernis, E., Khellaf, M., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076034 · Cited by 406
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care · doi:10.2337/dc09-0533 · Cited by 401
Jiang, Y., Genant, H. K., Watt, I., Cobby, M., Bresnihan, B., Aitchison, R., & McCabe, D. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1001::aid-anr7>3.0.co;2-p · Cited by 399
Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi, D., Poulakos, J., & Sun, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10870 · Cited by 392
Update on gout: new therapeutic strategies and options
Terkeltaub, R. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.236 · Cited by 387
Gattorno, M., Piccini, A., Lasigliè, D., Tassi, S., Brisca, G., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A., Caroli, F., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23437 · Cited by 382
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Vezzani, A., Maroso, M., Balosso, S., Sanchez, M.-A., & Bartfai, T. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.018 · Cited by 362
Abbate, A., Salloum, F. N., Vecile, E., Das, A., Hoke, N. N., Straino, S., Biondi-Zoccai, G. G. L., Houser, J.-E., Qureshi, I. Z., Ownby, E. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.740233 · Cited by 360
Rapid responses to anakinra in patients with refractory adult‐onset Still's disease
Fitzgerald, A. A., LeClercq, S. A., Yan, A., Homik, J. E., & Dinarello, C. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21061 · Cited by 350
Self-citationAnakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Increased Plasma Interleukin-1 Activity in Women After Ovulation
Cannon, J. G., & Dinarello, C. A. (1985) · Science · doi:10.1126/science.3871966 · Cited by 340
Self-citationCohen, I., Rider, P., Carmi, Y., Braiman, A., Dotan, S., White, M. R., Voronov, E., Martin, M. U., Dinarello, C. A., & Apte, R. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915018107 · Cited by 329
Self-citationJoosten, L. A. B., Netea, M. G., Mylona, E., Koenders, M. I., Malireddi, R. K. S., Oosting, M., Stienstra, R., van de Veerdonk, F. L., Stalenhoef, A. F., Giamarellos‐Bourboulis, E. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27667 · Cited by 328
Self-citationThe role of microparticles in the pathogenesis of rheumatic diseases
Beyer, C., & Pisetsky, D. S. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.229 · Cited by 324
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Meissner, F., Molawi, K., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002396107 · Cited by 318
Braun‐Falco, M., Kovnerystyy, O., Lohse, P., & Ruzicka, T. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.025 · Cited by 318
So, A., De Meulemeester, M., Pikhlak, A., Yücel, A. E., Richard, D., Murphy, V., Arulmani, U., Sallstig, P., & Schlesinger, N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27600 · Cited by 315
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 315
Gattorno, M., Pelagatti, M. A., Meini, A., Obici, L., Barcellona, R., Federici, S., Buoncompagni, A., Plebani, A., Merlini, G., & Martini, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23475 · Cited by 312
In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
Lachmann, H. J., Lowe, P., Felix, S. D., Rordorf, C., Leslie, K., Madhoo, S., Wittkowski, H., Bek, S., Hartmann, N., Bosset, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082481 · Cited by 312
Ikonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., & Kremastinos, D. T. (2008) · Circulation · doi:10.1161/circulationaha.107.731877 · Cited by 307
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
Fleischmann, R. M., Tesser, J., Schiff, M. H., Schechtman, J., Burmester, G.-R., Bennett, R., Modafferi, D., Zhou, L., Bell, D., & Appleton, B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048371 · Cited by 305
Terkeltaub, R., Sundy, J. S., Schumacher, H. R., Murphy, F., Bookbinder, S., Biedermann, S., Wu, R., Mellis, S., & Radin, A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108936 · Cited by 300
Stojanov, S., Lapidus, S., Chitkara, P., Feder, H., Salazar, J. C., Fleisher, T. A., Brown, M. R., Edwards, K. M., Ward, M. M., Colbert, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103681108 · Cited by 294
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Self-citationSevere imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Mazodier, K. (2005) · Blood · doi:10.1182/blood-2005-05-1980 · Cited by 290
Why not treat human cancer with interleukin-1 blockade?
Dinarello, C. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9229-0 · Cited by 277
Self-citationNeven, B., Marvillet, I., Terrada, C., Ferster, A., Boddaert, N., Couloignier, V., Pinto, G., Pagnier, A., Bodemer, C., Bodaghi, B., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25057 · Cited by 265
Gattorno, M., Tassi, S., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A., D'Osualdo, A., Buoncompagni, A., Alpigiani, M. G., Alessio, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22842 · Cited by 247
Lust, J. A., Lacy, M. Q., Zeldenrust, S. R., Dispenzieri, A., Gertz, M. A., Witzig, T. E., Kumar, S., Hayman, S. R., Russell, S. J., Buadi, F. K., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.2.114 · Cited by 246
Cohen, S. B., Proudman, S., Kivitz, A. J., Burch, F. X., Donohue, J. P., Burstein, D., Sun, Y.-N., Banfield, C., Vincent, M. S., Ni, L., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3430 · Cited by 246
Schlesinger, N., Mysler, E., Lin, H.-Y., De Meulemeester, M., Rovensky, J., Arulmani, U., Balfour, A., Krammer, G., Sallstig, P., & So, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144063 · Cited by 244
STOCK, T. C., BLOOM, B. J., WEI, N., ISHAQ, S., PARK, W., WANG, X., GUPTA, P., & MEBUS, C. A. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110874 · Cited by 243
Blockade of interleukin 1 in type 1 diabetes mellitus
Mandrup-Poulsen, T., Pickersgill, L., & Donath, M. Y. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.271 · Cited by 237
Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1α
Berda-Haddad, Y., Robert, S., Salers, P., Zekraoui, L., Farnarier, C., Dinarello, C. A., Dignat-George, F., & Kaplanski, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116848108 · Cited by 232
Self-citationVan Tassell, B. W., Arena, R. A., Toldo, S., Mezzaroma, E., Azam, T., Seropian, I. M., Shah, K., Canada, J., Voelkel, N. F., Dinarello, C. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033438 · Cited by 232
Self-citationVojinovic, J., Damjanov, N., D'Urzo, C., Furlan, A., Susic, G., Pasic, S., Iagaru, N., Stefan, M., & Dinarello, C. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30238 · Cited by 226
Self-citationThe role of macrophage-derived IL-1 in induction and maintenance of angiogenesis
Carmi, Y., Voronov, E., Dotan, S., Lahat, N., Rahat, M. A., Fogel, M., Huszar, M., White, M. R., Dinarello, C. A., & Apte, R. N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901511 · Cited by 224
Self-citationKuemmerle-Deschner, J. B., Hachulla, E., Cartwright, R., Hawkins, P. N., Tran, T. A., Bader-Meunier, B., Hoyer, J., Gattorno, M., Gul, A., Smith, J., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.152728 · Cited by 222
Sibley, C. H., Plass, N., Snow, J., Wiggs, E. A., Brewer, C. C., King, K. A., Zalewski, C., Kim, H. J., Bishop, R., Hill, S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34409 · Cited by 220
Granowitz, E. V., Porat, R., Mier, J. W., Pribble, J. P., Stiles, D. M., Bloedow, D. C., Catalano, M. A., Wolff, S. M., & Dinarello, C. A. (1992) · Cytokine · doi:10.1016/1043-4666(92)90078-6 · Cited by 220
Self-citationInterleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism
Kaplanski, G., Farnarier, C., Kaplanski, S., Porat, R., Shapiro, L., Bongrand, P., & Dinarello, C. (1994) · Blood · doi:10.1182/blood.v84.12.4242.bloodjournal84124242 · Cited by 209
Self-citationMeinzer, U., Quartier, P., Alexandra, J.-F., Hentgen, V., Retornaz, F., & Koné-Paut, I. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2010.11.003 · Cited by 205
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy
Chae, J. J., Aksentijevich, I., & Kastner, D. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07733.x · Cited by 205
British Journal of Clinical Pharmacology
(2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04428.x · Cited by 200
Chevalier, X., Giraudeau, B., Conrozier, T., Marliere, J., Kiefer, P., & Goupille, P. (2005) · PubMed · Cited by 197
Mansfield, E., Chae, J. J., Komarow, H. D., Brotz, T. M., Frucht, D. M., Aksentijevich, I., & Kastner, D. L. (2001) · Blood · doi:10.1182/blood.v98.3.851 · Cited by 197
Ruperto, N., Quartier, P., Wulffraat, N., Woo, P., Ravelli, A., Mouy, R., Bader‐Meunier, B., Vastert, S. J., Noseda, E., D'Ambrosio, D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33342 · Cited by 196
Simon, A., Park, H., Maddipati, R., Lobito, A. A., Bulua, A. C., Jackson, A. J., Chae, J. J., Ettinger, R., de Koning, H. D., Cruz, A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914118107 · Cited by 196
Self-citationSloan-Lancaster, J., Abu-Raddad, E., Polzer, J., Miller, J. W., Scherer, J. C., De Gaetano, A., Berg, J. K., & Landschulz, W. H. (2013) · Diabetes Care · doi:10.2337/dc12-1835 · Cited by 184
Zhang, K., Biroschak, J., Glass, D. N., Thompson, S. D., Finkel, T., Passo, M. H., Binstadt, B. A., Filipovich, A., & Grom, A. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23734 · Cited by 182
Kuemmerle-Deschner, J. B., Tyrrell, P. N., Koetter, I., Wittkowski, H., Bialkowski, A., Tzaribachev, N., Lohse, P., Koitchev, A., Deuter, C., Foell, D., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30149 · Cited by 177
Norheim, K. B., Harboe, E., Gøransson, L. G., & Omdal, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030123 · Cited by 176
On-demand anakinra treatment is effective in mevalonate kinase deficiency
Bodar, E. J., Kuijk, L. M., Drenth, J. P. H., van der Meer, J. W. M., Simon, A., & Frenkel, J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.149922 · Cited by 168
Self-citationBodar, E. J., van der Hilst, J. C. H., Drenth, J. P. H., van der Meer, J. W. M., & Simon, A. (2005) · PubMed · Cited by 166
Self-citationvan Asseldonk, E. J. P., Stienstra, R., Koenen, T. B., Joosten, L. A. B., Netea, M. G., & Tack, C. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2992 · Cited by 165
Beneficial response to interleukin 1 receptor antagonist in traps
Simon, A., Bodar, E. J., van der Hilst, J. C. H., van der Meer, J. W. M., Fiselier, T. J. W., Cuppen, M. P. J. M., & Drenth, J. P. H. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.039 · Cited by 164
Self-citationPicco, P. P., Brisca, G., Traverso, F., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24174 · Cited by 156
Alten, R., Gómez-Reino, J. J., Durez, P., Beaulieu, A. D., Sebba, A. I., Krammer, G., Preiss, R., Arulmani, U., Widmer, A., Gitton, X., et al. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-153 · Cited by 154
Topological Frustration and the Folding of Interleukin-1β
Gosavi, S., Chavez, L. L., Jennings, P. A., & Onuchic, J. N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.074 · Cited by 148
Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra
McGonagle, D. G., Tan, A. L., Shankaranarayana, S., Madden, J. M., Emery, P., & McDermott, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.073759 · Cited by 146
Rissanen, A., Howard, C. P., Botha, J., Thuren, T. Y., & for the Global Investigators (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01637.x · Cited by 143
Brück, N., Suttorp, M., Kabus, M., Heubner, G., Gahr, M. L., & Peßler, F. (2011) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318205092d · Cited by 142
Antin, J. H., Weinstein, H. J., Guinan, E., McCarthy, P. L., Bierer, B. E., Gilliland, D. G., Parsons, S. K., Ballen, K., Rimm, I., & Falzarano, G. (1994) · Blood · doi:10.1182/blood.v84.4.1342.1342 · Cited by 140
Schlesinger, N., Meulemeester, M. D., Pikhlak, A., Yücel, E., Richard, D., Murphy, V., Arulmani, U., Sallstig, P., & So, A. K.-L. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3297 · Cited by 139
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
de Koning, H. D., Bodar, E. J., Simon, A., van der Hilst, J. C. H., Netea, M. G., & van der Meer, J. W. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045245 · Cited by 138
Self-citationKötter, I., Wacker, A., Koch, S., Henes, J. C., Richter, C., Engel, A., Günaydın, İ., & Kanz, L. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.04.002 · Cited by 136
Koné‐Paut, I., Lachmann, H. J., Kuemmerle-Deschner, J. B., HACHULLA, E., Leslie, K. S., Mouy, R., Ferreira, A., Lheritier, K., Patel, N. P., Preiss, R., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3535 · Cited by 135
Moser, C. E., Pohl, G., Haslinger, I., Knapp, S., Rowczenio, D. M., Russel, T., Lachmann, H. J., Lang, U., & Kovarik, J. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn646 · Cited by 132
Functional analysis of the osteoarthritis susceptibility–associated GDF5 regulatory polymorphism
Egli, R. J., Southam, L., Wilkins, J. M., Lorenzen, I., Pombo‐Suárez, M., Gonzalez, A., Carr, A. J., Chapman, K. E., & Loughlin, J. A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24616 · Cited by 131
Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
Goldbach‐Mansky, R. T. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0165-y · Cited by 131
Galea, J. P., Ogungbenro, K., Hulme, S., Greenhalgh, A. D., Aarons, L. J., Scarth, S., Hutchinson, P. J., Grainger, S., King, A. T., Hopkins, S. J., et al. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.103 · Cited by 128
Successful treatment of resistant pseudogout with anakinra
McGonagle, D. G., Tan, A. L., Madden, J. M., Emery, P., & McDermott, M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23119 · Cited by 121
IL-1β Receptor Antagonist Reduces Inflammation in Hemodialysis Patients
Hung, A. M., Ellis, C. D., Shintani, A., Booker, C., & Ikizler, T. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070760 · Cited by 121
Kuemmerle-Deschner, J. B., Ramos, E., Blank, N., Roesler, J., Felix, S. D., Jung, T., Stricker, K., Chakraborty, A., Tannenbaum, S., Wright, A. M., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3266 · Cited by 121
de Jong, B. A., Huizinga, T. W. J., Bollen, E. L. E. M., Uitdehaag, B. M. J., Bosma, G. P. T., van Buchem, M. A., Remarque, E. J., Burgmans, A. C. S., Kalkers, N. F., Polman, C. H., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00056-5 · Cited by 119
Nedjai, B., Hitman, G. A., Quillinan, N., Coughlan, R. J., Church, L. D., McDermott, M., & Turner, M. D. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24294 · Cited by 117
Interleukin‐1 System in CNS Stress: Seizures, Fever, and Neurotrauma
Bartfai, T., Sánchez-Alavez, M., Andell, S., Schultzberg, M., Vezzani, A., Danielsson, E., & Conti, B. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.022 · Cited by 115
Lepore, L., Paloni, G., Caorsi, R., Alessio, M., Rigante, D., Ruperto, N., Cattalini, M., Tommasini, A., Zulian, F., Ventura, A., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.02.040 · Cited by 114
Abbate, A., Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Robati, R., Varma, A., Salloum, F. N., Smithson, L. A., & Dinarello, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq017 · Cited by 113
Self-citationAli, Z., Laurijssens, B. E., Ostenfeld, T., McHugh, S. M., Stylianou, A., Scott‐Stevens, P., Hosking, L. K., Dewit, O., Richardson, J. C., & Chen, C. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04320.x · Cited by 111
Cailliez, M., Garaix, F., Rousset‐Rouvière, C., et al. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0408-7 · Cited by 110
Stankovic, K., Delmas, Y., Ureña, P., Peltier, J., Pellé, G., Jéru, I., Colombat, M., & Grateau, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr528 · Cited by 110
Kamari, Y., Werman-Venkert, R., Shaish, A., Werman, A., Harari, A., Gonen, A., Voronov, E., Grosskopf, I., Sharabi, Y., Grossman, E., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.026 · Cited by 109
Self-citationHidradenitis Suppurativa and Concomitant Pyoderma Gangrenosum
Hsiao, J. L., Antaya, R. J., Berger, T. G., Maurer, T. A., Shinkai, K., & Leslie, K. S. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.328 · Cited by 106
Drevlow, B. E., Lovis, R. M., Haag, M. A., Sinacore, J. M., Jacobs, C. A., Blosche, C., LANDAY, A. L., Moreland, L. W., & Pope, R. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390212 · Cited by 103
Pathak, S., Goldofsky, E., Vivas, E. X., Bonagura, V. R., & Vambutas, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002275 · Cited by 99
Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
Bilginer, Y., Ayaz, N. A., & Özen, S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1279-8 · Cited by 95
Cryopyrin‐Associated Periodic Syndromes
Ahmadi, N., Brewer, C. C., Zalewski, C. K., King, K. A., Butman, J. A., Plass, N., Henderson, C., Goldbach‐Mansky, R. T., & Kim, H. J. (2011) · Otolaryngology · doi:10.1177/0194599811402296 · Cited by 93
Colina, M., Pizzirani, C., Khodeir, M., Falzoni, S., Bruschi, M., Trotta, F., & Virgilio, F. D. (2010) · Rheumatology · doi:10.1093/rheumatology/keq074 · Cited by 89
Macrophage Activation Syndrome Treated with Anakinra
DURAND, M., TROYANOV, Y., LAFLAMME, P., & GREGOIRE, G. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091046 · Cited by 86
Interleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage Destruction
Joosten, L. A. B., Smeets, R. L., Koenders, M. I., van den Bersselaar, L. A. M., Helsen, M. M. A., Oppers‐Walgreen, B., Lubberts, E., Iwakura, Y., van de Loo, F. A. J., & van den Berg, W. B. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63357-3 · Cited by 86
Rynne, M., Maclean, C., Bybee, A., McDermott, M. F., & Emery, P. E. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038091 · Cited by 86
THE ROLE OF INTERLEUKIN-1β IN THE PATHOGENESIS OF MULTIPLE MYELOMA
Lust, J. A., & Donovan, K. A. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70115-5 · Cited by 85
Neurologic manifestations of the cryopyrin-associated periodic syndrome
Kitley, J., Lachmann, H. J., Pinto, A. A., & Ginsberg, L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d9ed69 · Cited by 83
IL-1 regulates in vivo C—X—C chemokine induction and neutrophil sequestration following endotoxemia
Calkins, C. M., Bensard, D. D., Shames, B. D., Pulido, E. J., Abraham, E. H., Fernandez, N., Meng, X., Dinarello, C. A., & McIntyre, R. C. (2002) · Journal of Endotoxin Research · doi:10.1177/09680519020080010601 · Cited by 80
Self-citationDemyelinating events in rheumatoid arthritis after drug exposures
Bernatsky, S., Renoux, C., & Suissa, S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.111500 · Cited by 80
Erosive osteoarthritis of the hand: clinical experience with anakinra
Bacconnier, L., Jørgensen, C., & Fabre, S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094284 · Cited by 77
Sumpter, K., Adhikari, S., Grishman, E. K., & White, P. C. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00761.x · Cited by 76
Behrens, E. M., Kreiger, P. A., Cherian, S., & Cron, R. Q. (2006) · PubMed · Cited by 75
Announ, N., Palmer, G., Guerne, P., & Gabay, C. (2009) · Joint Bone Spine · doi:10.1016/j.jbspin.2009.01.001 · Cited by 74
van Asseldonk, E. J. P., van Poppel, P. C. M., Ballak, D. B., Stienstra, R., Netea, M. G., & Tack, C. J. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.06.003 · Cited by 71
Vambutas, A., DeVoti, J. A., Goldofsky, E., Gordon, M., LESSER, M. L., & Bonagura, V. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005293 · Cited by 68
Kondera‐Anasz, Z., Sikora, J., Mielczarek‐Palacz, A., & Jońca, M. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.04.019 · Cited by 66
Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes
Cavelti‐Weder, C., Furrer, R., Keller, C., Babians-Brunner, A., Solinger, A. M., Gast, H., Fontana, A., Donath, M. Y., & Penner, I. (2011) · Diabetes Care · doi:10.2337/dc11-1196 · Cited by 65
Drenth, J. P. H., van der Meer, J. W., & Kushner, I. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.400 · Cited by 62
Kuemmerle-Deschner, J. B., Lohse, P., Koetter, I., Dannecker, G. E., Reess, F., Ummenhofer, K., Koch, S., Tzaribachev, N., Bialkowski, A., & Benseler, S. M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3526 · Cited by 61
Case of anakinra as a steroid‐sparing agent for gout inflammation
Gratton, S. B., Scalapino, K. J., & Fye, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24694 · Cited by 60
Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury
Rusai, K., Huang, H., Sayed, N., et al. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00651.x · Cited by 58
Settas, L., Tsimirikas, G., Vosvotekas, G., Triantafyllidou, E., & Nicolaides, P. (2007) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31812e00a1 · Cited by 57
Spulber, S. D., Oprica, M., Bartfai, T., Winblad, B. G., & Schultzberg, M. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06050.x · Cited by 55
Mitroulis, I., Skendros, P., Oikonomou, A., Tzioufas, A. G., & Ritis, K. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146878 · Cited by 55
Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA)
Ohlsson, V., Baildam, E. M., Foster, H., Jandial, S., Pain, C. E., Strike, H., & Ramanan, A. V. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/ken030 · Cited by 55
Cantarini, L., Lucherini, O. M., Cimaz, R., & Galeazzi, M. (2010) · PubMed · Cited by 55
Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overview
Aronson, I. K., & Worobec, S. M. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01339.x · Cited by 54
Ogilvie, A. C., Hack, C. E., Wagstaff, J., van Mierlo, G. J., Erenberg, A. J., Thomsen, L. L., Hoekman, K., & Rankin, E. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.389 · Cited by 54
Furuta, T., Teranishi, M., Uchida, Y., Nishio, N., Kato, K., Otake, H., Yoshida, T., Tagaya, M., Suzuki, H., Sugiura, M., et al. (2011) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2011.01004.x · Cited by 53
Intravitreal Anakinra Inhibits Choroidal Neovascular Membrane Growth in a Rat Model
Olson, J. L., Courtney, R. J., Rouhani, B., Mandava, N., & Dinarello, C. A. (2009) · Ocular Immunology and Inflammation · doi:10.1080/09273940802710705 · Cited by 53
Self-citationBodar, E. J., Simon, A., de Visser, M., & van der Meer, J. W. M. (2009) · PubMed · Cited by 51
Self-citationSuccessful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
de Koning, H. D., Schalkwijk, J., van der Meer, J. W. M., & Simon, A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.023 · Cited by 50
Self-citationHyper-IgD syndrome or mevalonate kinase deficiency
Stoffels, M., & Simon, A. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349c3b1 · Cited by 48
Self-citationLehtimäki, K. A., Keränen, T., Palmio, J., & Peltola, J. (2009) · NeuroImmunoModulation · doi:10.1159/000243081 · Cited by 45
Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
Chevalier, X., Conrozier, T., & Richette, P. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3436 · Cited by 45
Xiong, Y., Donovan, K. A., Kline, M. P., Gornet, M. K., Moon‐Tasson, L. L., Lacy, M. Q., Dispenzieri, A. A., Gertz, M. A., Greipp, P. R., & Lust, J. A. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.83 · Cited by 43
Swart, J. F., Barug, D., Möhlmann, M., & Wulffraat, N. M. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.532785 · Cited by 42
IL-1 Inhibition With Anakinra in a Patient With Refractory Gout
Singh, D., & Huston, K. K. (2009) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3181be2423 · Cited by 39
Scott, I. C., Hajela, V., Hawkins, P. N., & Lachmann, H. J. (2011) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2011.07.003 · Cited by 34
Hennig, S., Bayegan, K., Uffmann, M., Thalhammer, F., & Winkler, S. (2010) · Rheumatology International · doi:10.1007/s00296-010-1429-y · Cited by 33
First observation of the efficacy of IL-1ra to treat tophaceous gout of the lumbar spine
Funck‐Brentano, T., Salliot, C., Leboime, A., Zafrani, L., Servais, A., Larousserie, F., & Dougados, M. (2010) · Rheumatology · doi:10.1093/rheumatology/keq358 · Cited by 23
Botsios, C., Sfriso, P., Furlan, A., Ostuni, P., Biscaro, M., Fiocco, U., TODESCO, S., & Punzi, L. (2011) · Reumatismo · doi:10.4081/reumatismo.2007.32 · Cited by 22
Anakinra for the inflammatory complications of chronic granulomatous disease.
van de Veerdonk, F. L., Netea, M. G., Dinarello, C. A., & van der Meer, J. W. M. (2011) · PubMed · Cited by 21
Self-citationKlein, A., & Horneff, G. (2010) · Klinische Pädiatrie · doi:10.1055/s-0029-1239527 · Cited by 20
Genant, H. K., Bresnihan, B., Ng, E., et al. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2001.1196 · Cited by 18
Takebe, N., Paredes, J., PINO, M. C., LOWNSBURY, W. H., Agosti, J. M., & Krown, S. E. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.321 · Cited by 11
Mueller, S. M., Itin, P. H., & Haeusermann, P. (2011) · Dermatology · doi:10.1159/000331580 · Cited by 8
Hong, D. S., Naing, A., Falchook, G. S., Piha-Paul, S. A., Wheler, J. J., Fu, S., Tsimberidou, A. M., Hui, D., Scott, R., Khan, R. S., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-11-a211 · Cited by 6
van Asseldonk, E., van Poppel, P. C. M., Ballak, D. B., et al. (2012) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-012-0135-7 · Cited by 4
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
“IL-1 affects virtually all cells and organs and is a major pathogenic mediator of autoinflammatory, autoimmune, infectious, and degenerative diseases (Dinarello, 2009, 2010; Dinarello et al., 2012; Gabay et al., 2010; Sims and Smith, 2010) (Table 2).”
Influential
Metadata
- Authors
- Dinarello, C. A., Simon, A., & van der Meer, J. W. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-08
- Volume
- 11
- Issue
- 8
- Pages
- 633-652
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2108373994
- Cited by
- 1,768
- References
- 189
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.